|
1.
|
|
8 p, 1.3 MB |
The Role of Digital Rectal Examination Prostate Volume Category in the Early Detection of Prostate Cancer : Its Correlation with the Magnetic Resonance Imaging Prostate Volume
/
Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Picola, Natàlia (Hospital Universitari de Bellvitge) ;
Muñoz-Rodríguez, Jesús (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Paesano, Nahuel (Clinica Creu Blanca) ;
Ruiz-Plazas, Xavier (Hospital Universitari de Tarragona Joan XXIII) ;
Muñoz-Rivero, Marta V. (Hospital Universitari Arnau de Vilanova) ;
Celma, Ana (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
García-de Manuel, Gemma (Hospital Universitari Josep Trueta) ;
Miró, Berta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ;
Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
To relate the prostate volume category (PVC) assessed with digital rectal examination (DRE)-small, median, and large-and the prostate volumes (PVs) assessed with magnetic resonance imaging (MRI) and transrectal ultrasound (TRUS). [...]
2024 -  10.5534/wjmh.230028
The world journal of men's health, Vol. 42 (january 2024) , p. 441-448
|
|
|
2.
|
|
9 p, 440.0 KB |
Effect of 5-Alpha Reductase Inhibitors on Magnetic Resonance Imaging and Prostate Cancer Detection
/
Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Picola, Natàlia (Hospital Universitari de Bellvitge) ;
Muñoz-Rodríguez, Jesús (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Paesano, Nahuel (Clínica Creu Blanca) ;
Ruiz-Plazas, Xavier (Hospital Universitari Joan XXIII de Tarragona) ;
Muñoz-Rivero, Marta V. (Hospital Universitari Arnau de Vilanova) ;
Celma, Ana (Hospital Universitari Vall d'Hebron) ;
Manuel, Gemma García-de (Hospital Universitari de Girona Doctor Josep Trueta) ;
Miró, Berta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Abascal, Jose Maria (Parc de Salut MAR de Barcelona)
Concerns exist regarding the effects of 5-alpha reductase inhibitors (5-ARIs) on multipa-rametric magnetic resonance imaging (mpMRI) and clinically significant prostate cancer (csPCa) detection. Our objective is to analyze the effect of 5-ARI on the prostate imaging-reporting and data system (PI-RADS) distribution and csPCa and insignificant PCa (iPCa) detection. [...]
2024 - 10.3390/biom14020193
Biomolecules, Vol. 14 (february 2024)
|
|
|
3.
|
|
36 p, 4.7 MB |
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
/
García-Vílchez, Raquel (Instituto de Investigación Biomédica de Salamanca) ;
Añazco-Guenkova, Ana M. (Instituto de Investigación Biomédica de Salamanca) ;
Dietmann, Sabine (Washington University School of Medicine in St. Lou) ;
López, Judith (Instituto de Investigación Biomédica de Salamanca) ;
Morón-Calvente, Virginia (Instituto de Investigación Biomédica de Salamanca) ;
D'Ambrosi, Silvia (CIC bioGUNE, Basque Research and Technology Alliance (BRTA)) ;
Nombela, Paz (Instituto de Investigación Biomédica de Salamanca) ;
Zamacola, Kepa (CIC bioGUNE, Basque Research and Technology Alliance (BRTA)) ;
Mendizabal, Isabel (CIC bioGUNE, Basque Research and Technology Alliance (BRTA)) ;
García-Longarte, Saioa (CIC bioGUNE, Basque Research and Technology Alliance (BRTA)) ;
Zabala-Letona, Amaia (Centro de Investigación Biomédica en Red de Cáncer) ;
Astobiza, Ianire (Centro de Investigación Biomédica en Red de Cáncer) ;
Fernández, Sonia (Centro de Investigación Biomédica en Red de Cáncer) ;
Paniagua, Alejandro (Universidad de Salamanca) ;
Miguel-López, Borja (Instituto de Investigación Biomédica de Salamanca) ;
Marchand, Virginie (Université de Lorraine, France) ;
Alonso-López, Diego (Universidad de Salamanca) ;
Merkel, Angelika (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
García-Tuñón, Ignacio (Universidad de Salamanca) ;
Ugalde-Olano, Aitziber (Hospital de Basurto (Bilbao, Biscaia)) ;
Loizaga-Iriarte, Ana (Hospital de Basurto (Bilbao, Biscaia)) ;
Lacasa-Viscasillas, Isabel (Hospital de Basurto (Bilbao, Biscaia)) ;
Unda, Miguel (Hospital de Basurto (Bilbao, Biscaia)) ;
Azkargorta, Mikel (Carlos III Networked Proteomics Platform (ProteoRed-ISCIII), Madrid) ;
Elortza, Félix (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Bárcena, Laura (CIC bioGUNE, Basque Research and Technology Alliance (BRTA)) ;
Gonzalez-Lopez, Monika (CIC bioGUNE, Basque Research and Technology Alliance (BRTA)) ;
Aransay, Ana M. (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Di Domenico, Tomás (Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO)) ;
Sánchez-Martín, Manuel A. (Universidad de Salamanca) ;
De Las Rivas, Javier (Universidad de Salamanca) ;
Guil, S. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Motorin, Yuri (Université de Lorrain) ;
Helm, Mark (Johannes Gutenberg-University Mainz, Germany) ;
Pandolfi, Pier Paolo (University of Turin, Italy) ;
Carracedo, Arkaitz (Centro de Investigación Biomédica en Red de Cáncer) ;
Blanco, Sandra (Universidad de Salamanca)
Newly growing evidence highlights the essential role that epitranscriptomic marks play in the development of many cancers; however, little is known about the role and implications of altered epitranscriptome deposition in prostate cancer. [...]
2023 - 10.1186/s12943-023-01809-8
Molecular cancer, Vol. 22 Núm. 1 (july 2023)
|
|
|
4.
|
|
8 p, 547.4 KB |
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
/
Du, Yong (The Royal Marsden NHS Foundation Trust) ;
Carrió, Ignasi (Institut d'Investigació Biomèdica Sant Pau) ;
De Vincentis, Giuseppe (Policlinico Umberto I University Hospital Rome) ;
Fanti, Stefano (University Hospital Bologna) ;
Ilhan, Harun (Ludwig-Maximilians-University Hospital) ;
Mommsen, Caroline (Praxis für diagnostische und therapeutische Nuklearmedizin Berlin) ;
Nitzsche, Egbert (Canton Hospital Aarau) ;
Sundram, Francis (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Vogel, Wouter (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Oyen, Wim (The Institute of Cancer Research) ;
Lewington, Val (Guy's and St Thomas' NHS Foundation Trust) ;
Universitat Autònoma de Barcelona
Radium Ra 223 dichloride (radium-223, Xofigo®) is the first targeted alpha therapy for patients with castration-resistant prostate cancer and symptomatic bone metastases. Radium-223 provides a new treatment option for this setting, but also necessitates a new treatment management approach. [...]
2017 - 10.1007/s00259-017-3756-7
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44 Núm. 10 (january 2017) , p. 1671-1678
|
|
|
5.
|
|
11 p, 1.5 MB |
Intermittent androgen deprivation therapy : Recommendations to improve the management of patients with prostate cancer following the GRADE approach
/
Bonfill, X. (Xavier) (Institut d'Investigació Biomèdica Sant Pau) ;
Arevalo-Rodriguez, Ingrid (Hospital Ramon y Cajal (IRYCIS)) ;
Martínez García, Laura (Institut d'Investigació Biomèdica Sant Pau) ;
Quintana Ruiz, Maria Jesús (Institut d'Investigació Biomèdica Sant Pau) ;
Buitrago-Garcia, Diana (Universidad Tecnológica Equinoccial) ;
Lobos Urbina, D. (Pontificia Universidad Católica de Chile) ;
Cordero, José Antonio (Universitat Ramon Llull) ;
Universitat Autònoma de Barcelona
The purpose of this study was to provide evidence-based recommendations of intermittent androgen deprivation therapy (IADT) compared with continuous androgen deprivation therapy (CADT) for men with prostate cancer (PCA). [...]
2018 - 10.2147/CMAR.S164856
Cancer Management and Research, Vol. 10 (2018) , p. 2357-2367
|
|
|
6.
|
|
10 p, 598.4 KB |
Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer : a systematic review
/
Vernooij, Robin W.M. (Netherlands Comprehensive Cancer Organisation) ;
Lytvyn, Lyubov (McMaster University (Canadà)) ;
Pardo-Hernandez, Hector (Institut d'Investigació Biomèdica Sant Pau) ;
Albarqouni, Loai (Bond University) ;
Canelo Aybar, Carlos Gilberto (Universidad Peruana de Ciencias Aplicadas) ;
Campbell, Karen (McMaster University (Canadà)) ;
Agoritsas, Thomas (Geneva University Hospitals) ;
Universitat Autònoma de Barcelona
To investigate men's values and preferences regarding prostate-specific antigen (PSA)-based screening for prostate cancer. Systematic review. We searched MEDLINE, EMBASE, PsycINFO and grey literature up to 2 September 2017. [...]
2018 - 10.1136/bmjopen-2018-025470
BMJ open, Vol. 8 Núm. 9 (2018) , p. e025470
|
|
|
7.
|
|
12 p, 2.4 MB |
Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
/
Page, Elizabeth C. (Institute of Cancer Research) ;
Bancroft, Elizabeth K. (Royal Marsden NHS Foundation Trust) ;
Brook, Mark N. (Institute of Cancer Research) ;
Assel, Melissa (Memorial Sloan Kettering Cancer Center) ;
Hassan Al Battat, Mona (Lund University) ;
Thomas, Sarah (Royal Marsden NHS Foundation Trust) ;
Taylor, Natalie (Royal Marsden NHS Foundation Trust) ;
Chamberlain, Anthony (Institute of Cancer Research) ;
Pope, Jennifer (Institute of Cancer Research) ;
Raghallaigh, Holly Ni (Institute of Cancer Research) ;
Evans, D.Gareth (Central Manchester University Hospitals NHS Foundation Trust) ;
Rothwell, Jeanette (Central Manchester University Hospitals NHS Foundation Trust) ;
Maehle, Lovise (Oslo University Hospital (Oslo, Noruega)) ;
Grindedal, Eli Marie (Oslo University Hospital (Oslo, Noruega)) ;
James, Paul (The Royal Melbourne Hospital) ;
Mascarenhas, Lyon (Peter MacCallum Cancer Centre) ;
McKinley, Joanne (Peter MacCallum Cancer Centre) ;
Side, Lucy (Princess Anne Hospital) ;
Thomas, Tessy (Princess Anne Hospital) ;
van Asperen, Christi (Leiden University Medical Center) ;
Vasen, Hans (The Foundation for the Detection of Hereditary Cancer) ;
Kiemeney, Lambertus A. (Radboud University Medical Center) ;
Ringelberg, Janneke (The Foundation for the Detection of Hereditary Cancer) ;
Jensen, Thomas Dyrso. (Vejle Hospital) ;
Osther, Palle J.S. (Vejle Hospital) ;
Helfand, Brian T. (NorthShore University HealthSystem) ;
Genova, Elena (NorthShore University HealthSystem) ;
Oldenburg, Rogier A. (Erasmus University Medical Center) ;
Cybulski, Cezary (Pomeranian Medical University in Szczecin) ;
Wokolorczyk, Dominika (Pomeranian Medical University in Szczecin) ;
Ong, Kai-Ren (Birmingham Women's Hospital) ;
Huber, Camilla (Birmingham Women's Hospital) ;
Lam, Jimmy (Bedford Park) ;
Taylor, Louise (Daw Park) ;
Salinas, Monica (Hospital Universitari de Bellvitge) ;
Feliubadaló, Lidia (Hospital Universitari de Bellvitge) ;
Oosterwijk, Jan C. (University of Groningen) ;
van Zelst-Stams, Wendy (Radboud University Medical Center) ;
Cook, Jackie (Sheffield Children's Hospital (Sheffield, Regne Unit)) ;
Rosario, Derek J. (Royal Hallamshire Hospital) ;
Domchek, Susan (Basser Research Center. University of Pennsylvania) ;
Powers, Jacquelyn (University of Pennsylvania) ;
Buys, Saundra (University of Utah) ;
O'Toole, Karen (University of Utah) ;
Ausems, Margreet G. E. M (University Medical Centre) ;
Schmutzler, Rita K. (University Hospital Cologne) ;
Rhiem, Kerstin (University Hospital Cologne) ;
Izatt, Louise (Guy's and St Thomas' NHS Foundation Trust) ;
Tripathi, Vishakha (Guy's and St Thomas' NHS Foundation Trust) ;
Teixeira, Manuel R. (Porto University) ;
Cardoso, Marta (Portuguese Oncology Institute (IPO Porto)) ;
Foulkes, William D. (McGill University, Departments of Human Genetics and Oncology) ;
Aprikian, Armen (Research Institute of McGill University Health Centre) ;
van Randeraad, Heleen (The Foundation for the Detection of Hereditary Cancer) ;
Davidson, Rosemarie (Queen Elizabeth University Hospital) ;
Longmuir, Mark (Queen Elizabeth University Hospital) ;
Ruijs, Marielle W.G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Helderman van den Enden, Apollonia T.J.M. (Maastricht University Medical Center) ;
Adank, Muriel (Amsterdam UMC) ;
Williams, Rachel (Prince of Wales Hospital (Australia)) ;
Andrews, Lesley (Prince of Wales Hospital (Australia)) ;
Murphy, Declan G. (Peter MacCallum Cancer Centre) ;
Halliday, Dorothy (Oxford Centre for Genomic Medicine) ;
Walker, Lisa (Oxford Centre for Genomic Medicine) ;
Liljegren, Annelie (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Carlsson, Stefan (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Azzabi, Ashraf (Newcastle upon Tyne Hospitals) ;
Jobson, Irene (Newcastle upon Tyne Hospitals) ;
Morton, Catherine (The Royal Melbourne Hospital) ;
Shackleton, Kylie (The Royal Melbourne Hospital) ;
Snape, Katie (St George's Hospital) ;
Hanson, Helen (St George's Hospital) ;
Harris, Marion (Monash Health) ;
Tischkowitz, Marc (University of Cambridge) ;
Taylor, Amy (Cambridge University Hospitals NHS Trust) ;
Kirk, Judy (Sydney Medical School) ;
Susman, Rachel (Royal Brisbane & Women's Hospital) ;
Chen-Shtoyerman, Rakefet (Kaplan Medical Center) ;
Spigelman, Allan (The Kinghorn Cancer Centre. St Vincent's Hospital) ;
Pachter, Nicholas (University of Western Australia) ;
Ahmed, Munaza (NE Thames Regional Genetics Service) ;
Ramon y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ;
Zgajnar, Janez (Institute of Oncology) ;
Brewer, Carole (Royal Devon and Exeter Hospital) ;
Gadea, Neus (Hospital Universitari Vall d'Hebron) ;
Brady, Angela F. (London North West University Healthcare NHS Trust) ;
van Os, Theo (Academic Medical Center) ;
Gallagher, David (St James's Hospital) ;
Johannsson, Oskar (Landspitali University Hospital (Reykjavík, Islàndia)) ;
Donaldson, Alan (St Michael's Hospital) ;
Barwell, Julian (University Hospitals Leicester) ;
Nicolai, Nicola (Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Friedman, Eitan (Chaim Shema Medical Center) ;
Obeid, Elias (Fox Chase Cancer Center) ;
Greenhalgh, Lynn (Liverpool Women's Hospital) ;
Murthy, Vedana (Tata Memorial Centre) ;
Copakova, Lucia (National Cancer Institute) ;
Saya, Sibel (Institute of Cancer Research) ;
McGrath, John (University of Exeter Medical School) ;
Cooke, Peter (New Cross Hospital) ;
Rønlund, Karina (Vejle Hospital) ;
Richardson, Kate (Peter MacCallum Cancer Centre) ;
Henderson, Alex (West Cumberland Infirmary) ;
Teo, Soo H. (Subang Jaya Medical Centre) ;
Arun, Banu (The University of Texas) ;
Kast, Karin (Technische Universität Dresden) ;
Dias, Alexander (Instituto Nacional de Cancer Jose de Alencar Gomes da Silva (INCA)) ;
Aaronson, Neil K (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Ardern-Jones, Audrey (Royal Marsden NHS Foundation Trust) ;
Bangma, Chris H. (Erasmus University Medical Center) ;
Castro, Elena (Centro Nacional de Investigaciones Oncológicas) ;
Dearnaley, David (The Institute of Cancer Research. Royal Marsden NHS Foundation Trust (Londres, Regne Unit)) ;
Eccles, Diana M. (The University of Southampton Medical School) ;
Tricker, Karen (Central Manchester University Hospitals NHS Foundation Trust) ;
Eyfjord, Jorunn (University of Iceland) ;
Falconer, Alison (Imperial College Healthcare NHS Trust) ;
Foster, Christopher (HCA Pathology Laboratories) ;
Gronberg, Henrik (University Hospital) ;
Hamdy, Freddie C. (University of Oxford) ;
Stefansdottir, Vigdis (Landspitali University Hospital (Reykjavík, Islàndia)) ;
Khoo, Vincent (The University of Melbourne) ;
Lindeman, Geoffrey J. (The Walter and Eliza Hall Institute of Medical Research) ;
Lubinski, Jan (Pomeranian Medical University in Szczecin) ;
Axcrona, Karol (Akershus University Hospital) ;
Mikropoulos, Christos (Medway Hospital) ;
Mitra, Anita (University College London Hospitals NHS Foundation Trust) ;
Moynihan, Clare (Institute of Cancer Research) ;
Rennert, Gadi (Carmel Medical Center) ;
Suri, Mohnish (Nottingham City Hospital) ;
Wilson, Penny (Innovate UK. Polaris House) ;
Dudderidge, Tim (University Hospital Southampton) ;
Offman, Judith (King's College London) ;
Kote-Jarai, Zsofia (Institute of Cancer Research) ;
Vickers, Andrew (Memorial Sloan Kettering Cancer Center) ;
Lilja, Hans (Memorial Sloan-Kettering Cancer Center (Nova York, Estats Units d'Amèrica)) ;
Eeles, Rosalind A. (Royal Marsden NHS Foundation Trust) ;
Universitat Autònoma de Barcelona
Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-antigen (PSA) in men with germline BRCA1/2 mutations. [...]
2019 - 10.1016/j.eururo.2019.08.019
European Urology, Vol. 76 Núm. 6 (december 2019) , p. 831-842
|
|
|
8.
|
|
28 p, 397.3 KB |
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
/
Lam, Thomas B.L. (Aberdeen Royal Infirmary) ;
MacLennan, Steven (University of Aberdeen) ;
Willemse, Peter-Paul M. (University Medical Center Utrecht) ;
Mason, Malcolm D. (Velindre Cancer Centre) ;
Plass, Karin (EAU Guidelines Office) ;
Shepherd, Robert (EAU Guidelines Office) ;
Baanders, Ruud ;
Bangma, Chris H. (Erasmus University Medical Centre) ;
Bjartell, Anders (Lund University) ;
Bossi, Alberto (Gustave Roussy Institute) ;
Briers, Erik ;
Briganti, Alberto (IRCCS Ospedale San Raffaele (Milà, Itàlia)) ;
Buddingh, Karel T. (HagaZiekenhuis) ;
Catto, James W.F. (Royal Hallamshire Hospital) ;
Colecchia, Maurizio (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) ;
Cox, Brett W. (Zucker School of Medicine) ;
Cumberbatch, Marcus G. (University of Sheffield) ;
Davies, Jeff ;
Davis, Niall F. (Royal College of Surgeons in Ireland) ;
De Santis, Maria (Charité University Hospital) ;
Dell'Oglio, Paolo (ORSI Academy) ;
Deschamps, André (Europa Uomo) ;
Donaldson, James F. (Aberdeen Royal Infirmary) ;
Egawa, Shin (Jikei University School of Medicine) ;
Fankhauser, Christian D. (University of Zurich) ;
Fanti, Stefano (University of Bologna) ;
Fossati, Nicola (Scientific Institute and University Vita-Salute San Raffaele Hospital) ;
Gandaglia, Giorgio (IRCCS Ospedale San Raffaele) ;
Gillessen, Silke (University of Bern) ;
Grivas, Nikolaos (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Gross, Tobias (University of Bern) ;
Grummet, Jeremy P. (Monash University) ;
Henry, Ann M. (St. James's University Hospital) ;
Ingels, Alexandre (Henri Mondor Hospital) ;
Irani, Jacques (University Hospital of Bicêtre-Paris Sud-Saclay University) ;
Lardas, Michael (Department of Reconstructive Urology and Surgical Andrology) ;
Liew, Matthew (Wigan and Leigh NHS Foundation Trust) ;
Lin, Daniel W. (University of Washington) ;
Moris, Lisa (KU Leuven) ;
Omar, Muhammad Imran (University of Aberdeen) ;
Pang, Karl H. (University of Sheffield) ;
Paterson, Catherine C. (Robert Gordon University) ;
Renard-Penna, Raphaële (Sorbonne Université) ;
Ribal, María J. (Hospital Clínic i Provincial de Barcelona) ;
Roobol, M.J. (Erasmus University Medical Centre) ;
Rouprêt, Morgan (Sorbonne Université) ;
Rouvière, Olivier (Université de Lyon) ;
Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Richenberg, Jonathan (Royal Sussex County Hospital Brighton and Brighton and Sussex Medical School) ;
Schoots, Ivo G. (Erasmus University Medical Center) ;
Sedelaar, J.P.Michiel (Radboud University Medical Centre) ;
Stricker, Phillip (Garvan Institute of Research) ;
Tilki, Derya (University Hospital Hamburg-Eppendorf) ;
Vahr Lauridsen, Susanne (Copenhagen University Hospital) ;
van den Bergh, Roderick C.N. (St. Antonius Hospital) ;
Van den Broeck, Thomas (University Hospitals Leuven (Bèlgica)) ;
van der Kwast, Theodorus H. (Erasmus University Medical Center) ;
van der Poel, Henk G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
van Leenders, Geert J.L.H. (Erasmus University Medical Center) ;
Varma, Murali (University Hospital of Wales) ;
Violette, Philippe D. (McMaster University (Canadà)) ;
Wallis, Christopher J.D. (Vanderbilt University Medical Center) ;
Wiegel, Thomas (University Hospital of Ulm (Alemanya)) ;
Wilkinson, Karen (University College London Hospitals) ;
Zattoni, Fabio (Academic Medical Centre Hospital) ;
N'Dow, James M.O. (Aberdeen Royal Infirmary) ;
Van Poppel, Hendrik (University Hospitals Leuven (Bèlgica)) ;
Cornford, Philip (Royal Liverpool and Broadgreen Hospitals NHS Trust) ;
Mottet, Nicolas (University Hospital Jean Monnet) ;
Universitat Autònoma de Barcelona
There is uncertainty in deferred active treatment (DAT) programmes, regarding patient selection, follow-up and monitoring, reclassification, and which outcome measures should be prioritised. To develop consensus statements for all domains of DAT. [...]
2019 - 10.1016/j.eururo.2019.09.020
European Urology, Vol. 76 Núm. 6 (december 2019) , p. 790-813
|
|
|
9.
|
|
16 p, 2.0 MB |
Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis
/
Barceló, Maria (Hospital Universitari de Bellvitge) ;
Castells, Manel (Hospital Universitari de Bellvitge) ;
Bassas, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Vigués, Francesc (Hospital Universitari de Bellvitge) ;
Larriba, Sara (Hospital Universitari de Bellvitge) ;
Universitat Autònoma de Barcelona
Although it is specific for prostatic tissue, serum prostate-specific antigen (PSA) screening has resulted in an over-diagnosis of prostate cancer (PCa) and many unnecessary biopsies of benign disease due to a well-documented low cancer specificity, thus improvement is required. [...]
2019 - 10.1038/s41598-019-50172-6
Scientific reports, Vol. 9 Núm. 1 (january 2019) , p. 13772
|
|
|
10.
|
|
12 p, 144.7 KB |
Expert recommendations on the management of patients with metastatic castration-resistant prostate cancer who progress after CHAARTED or LATITUDE
/
Puente, J. (Medical Oncology Department. Hospital Clínico San Carlos. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC). CIBERONC) ;
Anido, Urbano (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Climent, M.Á. (Instituto Valenciano de Oncología (IVO)) ;
Gonzalez-Billalabeitia, E. (Universidad Católica San Antonio de Murcia-UCAM) ;
Lainez, N. (Complejo Hospitalario de Navarra) ;
Lambea, Julio (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Mendez-Vidal, M.J. (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ;
Montesa, Álvaro (Hospital Regional Universitario de Málaga) ;
Rodriguez, A. (Hospital Universitario de León) ;
Zambrana, C. (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ;
González-del-Alba, A. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Universitat Autònoma de Barcelona
Our aim was to provide practical recommendations on the management of patients with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after docetaxel plus androgen-deprivation therapy (ADT) or abiraterone plus ADT. [...]
2020 - 10.1177/1758835920920067
Therapeutic Advances in Medical Oncology, Vol. 12 (2020)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
